Maryland Labor Secretary Tiffany P. Robinson Monday announced the award of more than $1.2 million in state funds to grow the department’s Employment Advancement Right Now (EARN) Maryland program. ...
Lockheed Martin Skunk Works® thrives on tackling seemingly impossible work, developing technologies for tomorrow’s challenges before the need is even identified. ...
The data security company earned the patent, the issuance of which Ardent Privacy announced today, for tech that a statement said allows clients to conduct “data minimization without reading data content. For those who aren’t data experts, this means that the data compliance tool allows companies to track, find and delete your data more easily without infringing upon data protection laws. ...
Celebrating its five-year anniversary the LifeBridge Health Bioincubator has landed nearly $60 million in funding from 36 grants and received 36 patents. Serving as the state’s only hospital-based bioincubator, the facility has launched several companies with potentially groundbreaking technologies, including gene therapy for cystic fibrosis, an ingestible capsule for the early detection of esophageal cancer, and an ultrasound-enabled bedside feeding tube. ...
The world looked very different 25 years ago – Blockbuster Video was still king of movie rentals, the Palm Pilot had just been introduced to the world, and the launch of the first generation iPhone was still a decade away. The connectivity landscape was sparse, and the world wide web was still just a novelty, not the necessity it is today. It was also the time when Hughes invented satellite internet to help improve the dial-up experience. Since then, satellite internet has become a staple for millions of homes and businesses in rural locations and has grown to support email, social media, web browsing, videos and more. ...
GAITHERSBURG, Md., May 16, 2022 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into a definitive agreement with Chimerix, Inc. (NASDAQ: CMRX), to acquire Chimerix’s exclusive worldwide rights to TEMBEXA® (brincidofovir), the first antiviral approved by the U.S. Food and Drug Administration (FDA) for all age groups for the treatment of smallpox. TEMBEXA was approved in June 2021 and is indicated for the treatment of human smallpox disease in adult and pediatric patients, including neonates. ...
The National Institutes of Health (NIH) is a critical pillar of the U.S. public health system and a beacon of guidance for healthcare best practices across the globe. This has never been more evident than during the COVID-19 crisis. ...
Rockville, Maryland’s American Gene Technologies (AGT), a leading gene therapy biotech company working to develop a functional cure for HIV and treatments for other diseases, recently launched a new HIV-focused video series entitled, “The Cure Chronicles.” ...
Key Points ...